Abeona Therapeutics Inc. - Common Stock (ABEO)
5.4850
+0.0150 (0.27%)
Abeona Therapeutics is a biotechnology company focused on developing innovative gene and cell therapies for the treatment of rare diseases and genetic disorders
The company is dedicated to advancing its proprietary platform technologies to create targeted therapies that can address the underlying causes of these conditions. Through its research and development efforts, Abeona aims to bring transformative treatments to patients, leveraging its expertise in gene delivery and cell-based therapies to provide hope for those suffering from debilitating illnesses.
Frequently Asked Questions
Is Abeona Therapeutics Inc. - Common Stock publicly traded?
Yes, Abeona Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Abeona Therapeutics Inc. - Common Stock trade on?
Abeona Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Abeona Therapeutics Inc. - Common Stock?
The ticker symbol for Abeona Therapeutics Inc. - Common Stock is ABEO on the Nasdaq Stock Market
What is the current price of Abeona Therapeutics Inc. - Common Stock?
The current price of Abeona Therapeutics Inc. - Common Stock is 5.485
When was Abeona Therapeutics Inc. - Common Stock last traded?
The last trade of Abeona Therapeutics Inc. - Common Stock was at 9:31 am EST on January 31st, 2025
What is the market capitalization of Abeona Therapeutics Inc. - Common Stock?
The market capitalization of Abeona Therapeutics Inc. - Common Stock is 238.44M
How many shares of Abeona Therapeutics Inc. - Common Stock are outstanding?
Abeona Therapeutics Inc. - Common Stock has 43.47M shares outstanding.